NCT06846645View on ClinicalTrials.gov

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Not yet recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

December 31, 2028

Conditions
Single Cell Sequencing TechnologyGene Expression ProfilingGene ExpressionInfectionViral DiseasesBacterial DiseasesActive TuberculosisHost Defense MechanismsHost Microbial InteractionsTranscriptome
Interventions
OTHER

No intervention

Patients will receive clinical treatment with no special intervention in this observational study. There is no difference in term of treatment of patients. It only involves one additional blood sampling early after admission.

Trial Locations (1)

Unknown

Dept of Chemical Pathology, Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT06846645 - Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis. | Biotech Hunter | Biotech Hunter